^
BIOMARKER:

ATRX mutation

i
Other names: ATRX, ATRX Chromatin Remodeler, Transcriptional Regulator ATRX, ATP-Dependent Helicase ATRX, X-Linked Nuclear Protein, X-Linked Helicase II, XH2, XNP, Alpha Thalassemia/Mental Retardation Syndrome X-Linked (RAD54 (S. Cerevisiae) Homolog), Alpha Thalassemia/Mental Retardation Syndrome X-Linked (RAD54 Homolog S. Cerevisiae), Alpha Thalassemia/Mental Retardation Syndrome X-Linked, Mental Retardation X-Linked 52, RAD54 Homolog (S. Cerevisiae), Juberg-Marsidi Syndrome, ZNF-HX, Znf-HX, MRX52, JMS
Entrez ID:
Related biomarkers:
ATRX mutation
Prostate Cancer
olaparib
Sensitive: C2 – Inclusion Criteria
ATRX mutation
Gastroesophageal Junction Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
ATRX mutation
Gastric Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
ATRX mutation
Leiomyosarcoma
eribulin mesylate
Resistant: C3 – Early Trials
ATRX mutation
Leiomyosarcoma
dacarbazine
Resistant: C3 – Early Trials
ATRX mutation
Triple Negative Breast Cancer
olaparib
Sensitive: C3 – Early Trials
ATRX mutation
Gastric Cancer
Immunotherapy
Sensitive: C3 – Early Trials
ATRX mutation
Neuroblastoma
AZD1775
Sensitive: C3 – Early Trials
ATRX mutation
GBM
selumetinib
Sensitive: D – Preclinical